Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-000503
Filing Date
2021-03-31
Accepted
2021-03-31 16:11:25
Documents
1
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 kintara_fm4mar312021.html 4  
1 kintara_fm4mar312021.xml 4 4228
  Complete submission text file 0000905718-21-000503.txt   5739
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 SAN MATEO DR MENLO PARK CA 94025
Business Address
Brown Dennis M (Reporting) CIK: 0001569520 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 21793401